BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32114850)

  • 1. Risk of Developing Hypokalemia in Patients With Hypertension Treated With Combination Antihypertensive Therapy.
    Krogager ML; Mortensen RN; Lund PE; Bøggild H; Hansen SM; Kragholm K; Aasbjerg K; Søgaard P; Torp-Pedersen C
    Hypertension; 2020 Apr; 75(4):966-972. PubMed ID: 32114850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trend of first-line drug choice and treatment continuity for hypertension among citizens 75 years or over - a register-based, cohort study.
    Nielsen SK; Lamberts M; Nouhravesh N; Jensen MH; Strange JE; Gislason G; Mcgettigan P; Holt A
    Int J Cardiol; 2024 Aug; 408():132137. PubMed ID: 38705205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
    Lu Y; Van Zandt M; Liu Y; Li J; Wang X; Chen Y; Chen Z; Cho J; Dorajoo SR; Feng M; Hsu MH; Hsu JC; Iqbal U; Jonnagaddala J; Li YC; Liaw ST; Lim HS; Ngiam KY; Nguyen PA; Park RW; Pratt N; Reich C; Rhee SY; Sathappan SMK; Shin SJ; Tan HX; You SC; Zhang X; Krumholz HM; Suchard MA; Xu H
    JAMA Netw Open; 2022 Mar; 5(3):e223877. PubMed ID: 35323951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands.
    Li X; Bijlsma MJ; Bos JHJ; Schuiling-Veninga CCM; Hak E
    BMJ Open; 2023 Aug; 13(8):e068721. PubMed ID: 37558444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative Incidence of Thiazide-Induced Hyponatremia : A Population-Based Cohort Study.
    Andersson NW; Wohlfahrt J; Feenstra B; Hviid A; Melbye M; Lund M
    Ann Intern Med; 2024 Jan; 177(1):1-11. PubMed ID: 38109740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
    Burke TA; Sturkenboom MC; Ohman-Strickland PA; Wentworth CE; Rhoads GG
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):979-87. PubMed ID: 17605137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice.
    Burke TA; Sturkenboom MC; Lu SE; Wentworth CE; Lin Y; Rhoads GG
    J Hypertens; 2006 Jun; 24(6):1193-200. PubMed ID: 16685222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target Blood Pressure and Combination Therapy: Focus on Angiotensin Receptor Blockers Combination with Either Calcium Channel Blockers or Beta Blockers.
    Farag SM; Rabea HM; Abdelrahim ME; Mahmoud HB
    Curr Hypertens Rev; 2022; 18(2):138-144. PubMed ID: 36508272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Blocker-Associated Risks in Patients With Uncomplicated Hypertension Undergoing Noncardiac Surgery.
    Jørgensen ME; Hlatky MA; Køber L; Sanders RD; Torp-Pedersen C; Gislason GH; Jensen PF; Andersson C
    JAMA Intern Med; 2015 Dec; 175(12):1923-31. PubMed ID: 26436291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
    Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
    Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological hypertension therapy].
    Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
    Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between antihypertensive therapy and the incidence of Parkinson's disease in patients followed in general practices in Germany
.
    Warda A; Reese JP; Tanislav C; Kostev K
    Int J Clin Pharmacol Ther; 2019 Oct; 57(10):483-488. PubMed ID: 31426904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study.
    Ardissino M; Slob EAW; Rajasundaram S; Reddy RK; Woolf B; Girling J; Johnson MR; Ng FS; Gill D
    BMC Med; 2022 Sep; 20(1):288. PubMed ID: 36064525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-Angiotensin-Aldosterone System-based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries.
    Htoo PT; Stürmer T; Jonsson-Funk M; Pate V; Simpson RJ; Lund JL
    Epidemiology; 2019 Nov; 30(6):867-875. PubMed ID: 31348009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations Among Visit-to-Visit Blood Pressure Variability and Treatment With Antihypertensive Medication With Long-Term Adverse Outcomes in a Large Veteran Cohort.
    Basson MD; Newman WE; Klug MG
    Am J Hypertens; 2021 Oct; 34(10):1092-1099. PubMed ID: 34115112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
    Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
    Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients.
    Cho MA; Jeong SY; Sohn I; Kim MS; Kang JH; Paik ES; Lee YY; Choi CH
    Cancer Res Treat; 2020 Apr; 52(2):645-654. PubMed ID: 32019281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Medication Selection Model Under Clinical Application of Renin-Angiotensin Inhibitor Combined with Calcium Channel Blocker for Hypertension Patients.
    Hong D; Shi W; Lu X; Lou Y; Li L
    Med Sci Monit; 2020 Apr; 26():e923696. PubMed ID: 32285846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.